Lipella Pharmaceuticals Inc. (LIPO): Valuation
TTM figures as of September 30, 2025
Earnings yield -230,683.56%.
45 month-end valuation observations are on file, starting December 2022.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is LIPO cheap versus its own history?
This page compares Lipella Pharmaceuticals Inc.'s live multiples to its own month-end history back to 2022 and to the median of its sector. A multiple is withheld until twenty monthly observations exist.
What is LIPO's free-cash-flow yield?
Free-cash-flow yield is trailing free cash flow divided by the live market cap. It is omitted when free cash flow is missing.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.